[ad_1]
Own report: One of the volunteers unexpectedly fell ill after receiving the vaccine! British pharmaceutical giant AstraZeneca has since discontinued testing of the ticker in Britain. The Comptroller General of Drugs of India (DCGI), the central regulator, sent a notice to the Serum Institute shortly after the trial of the vaccine in Britain. Ultimately, the Corona Covishield vaccine trial conducted by Oxford scientists was also suspended in India on instructions from the Central Regulatory Authority.
In a notification sent to the Serum Institute, India’s Comptroller General of Drugs wants to know why the process will continue in India, where the trial has been temporarily suspended due to safety concerns in the UK. Why would the Serum Institute be granted an exemption for this ticker trial without being sure of the safety of the ticker?
In response to the advisory, the Serum Institute said the company would abide by all instructions from DCGI. Any security issues will be resolved in accordance with DCGI’s instructions. The third phase of Covishield’s trial in India was scheduled to begin next week, the agency said. But the trial will continue until the safety of the vaccine is confirmed.
British pharmaceutical giant AstraZeneca has already started production of this corona antidote, developed by researchers at the University of Oxford. The world’s largest vaccine manufacturer, the Serum Institute of India, has also started production of the vaccine. The Ticker trial (AZD1222) has been stopped and the volunteer has become ill. In addition to Great Britain and India, the Oxford Corona Ticker trial has been suspended in the United States, Brazil and South Africa.
Read more: Big boost! Volunteer sick after receiving corona vaccine at Oxford! Postponed rehearsal of the last episode
It is known that after this incident, the AstraZeneca Review Committee will re-examine the adverse effects of the vaccine. Review committee members will investigate why such incidents occurred after the success of the first and second rounds of Ticker testing. However, as long as the review committee gives the green signal, the trial of the last stage of the vaccine will be postponed.
[ad_2]
